Literature DB >> 12888534

General plasmids for producing RNA in vitro transcripts with homogeneous ends.

Scott C Walker1, Johanna M Avis, Graeme L Conn.   

Abstract

In vitro transcripts of bacteriophage RNA polymerases (RNAPs), such as T7 RNAP, often suffer from a considerable degree of 3'-end heterogeneity and, with certain promoter sequences, 5'-end heterogeneity. For some applications, this transcript heterogeneity poses a significant problem. A potential solution is to incorporate ribozymes into the transcripts at the 5'- and/or 3'-end of the target RNA sequence. This approach has been used quite widely but has required the generation of new transcription vectors or PCR-derived templates for each new RNA to be studied. To overcome this limitation, we have created two general plasmids for producing homogeneous RNA transcripts: one encodes a 3'- hepatitis delta virus (HDV) ribozyme and the other, used in combination with a two-step PCR, allows the production of double [5'-hammerhead (HH) and 3'-HDV] ribozyme constructs. A choice of cloning and run-off transcription linearisation restriction enzyme sites ensures that virtually any RNA sequence can be cloned and transcribed from these plasmids. For all the RNA sequences tested, good yields of transcript were obtained. These plasmids provide the tools for the simple, rapid creation of new RNA-coding plasmids to produce milligram quantities of homogeneous in vitro transcripts for all applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888534      PMCID: PMC169970          DOI: 10.1093/nar/gng082

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

Review 1.  Structure, folding and catalysis of the small nucleolytic ribozymes.

Authors:  D M Lilley
Journal:  Curr Opin Struct Biol       Date:  1999-06       Impact factor: 6.809

Review 2.  Ribozyme structures and mechanisms.

Authors:  E A Doherty; J A Doudna
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001

Review 3.  In vitro selection of hammerhead ribozyme sequence variants.

Authors:  F Eckstein; A R Kore; K L Nakamaye
Journal:  Chembiochem       Date:  2001-09-03       Impact factor: 3.164

4.  A universal method to produce in vitro transcripts with homogeneous 3' ends.

Authors:  Heike Schürer; Kathrin Lang; Jens Schuster; Mario Mörl
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

5.  In vitro RNA synthesis with SP6 RNA polymerase.

Authors:  P A Krieg; D A Melton
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Preparation of specific ribosomal RNA fragments.

Authors:  D E Draper; S A White; J M Kean
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

7.  A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure.

Authors:  E T Schenborn; R C Mierendorf
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

8.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

9.  Effect of magnesium ions on the tertiary structure of the hepatitis C virus IRES and its affinity for the cyclic peptide antibiotic viomycin.

Authors:  Siska Vos; David J Berrisford; Johanna M Avis
Journal:  Biochemistry       Date:  2002-04-30       Impact factor: 3.162

10.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

Authors:  J F Milligan; D R Groebe; G W Witherell; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

View more
  54 in total

1.  Molecular basis for interaction of let-7 microRNAs with Lin28.

Authors:  Yunsun Nam; Casandra Chen; Richard I Gregory; James J Chou; Piotr Sliz
Journal:  Cell       Date:  2011-11-10       Impact factor: 41.582

2.  Superior 5' homogeneity of RNA from ATP-initiated transcription under the T7 phi 2.5 promoter.

Authors:  Tricia M Coleman; Guocan Wang; Faqing Huang
Journal:  Nucleic Acids Res       Date:  2004-01-15       Impact factor: 16.971

3.  A general method for rapid and nondenaturing purification of RNAs.

Authors:  Jeffrey S Kieft; Robert T Batey
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

4.  A novel 4-base-recognizing RNA cutter that can remove the single 3' terminal nucleotides from RNA molecules.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2004-06-28       Impact factor: 16.971

5.  Generating in vitro transcripts with homogenous 3' ends using trans-acting antigenomic delta ribozyme.

Authors:  Agnieszka Wichlacz; Michał Legiewicz; Jerzy Ciesiołka
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

6.  How U38, 39, and 40 of many tRNAs become the targets for pseudouridylation by TruA.

Authors:  Sun Hur; Robert M Stroud
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

7.  Nucleic acid structure characterization by small angle X-ray scattering (SAXS).

Authors:  Jordan E Burke; Samuel E Butcher
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2012-12

8.  A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.

Authors:  Anne L Hotard; Fyza Y Shaikh; Sujin Lee; Dan Yan; Michael N Teng; Richard K Plemper; James E Crowe; Martin L Moore
Journal:  Virology       Date:  2012-10-11       Impact factor: 3.616

9.  The PKR-binding domain of adenovirus VA RNAI exists as a mixture of two functionally non-equivalent structures.

Authors:  Ahmed M Wahid; Veronica K Coventry; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2009-07-27       Impact factor: 16.971

10.  Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase.

Authors:  Yasmin Chaudhry; Michael A Skinner; Ian G Goodfellow
Journal:  J Gen Virol       Date:  2007-08       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.